MDA/ALS Center

ALS team members at Houston Methodist Neurological Institute
The MDA/ALS Center at Methodist Neurological Institute is the first multidisciplinary care center for patients with ALS in the United States. Amyotrophic lateral sclerosis (ALS ) is one of the most challenging disorders facing those affected, as well as their families. For patients suffering from ALS, every day is a battle that demands inner strength and tremendous courage. For their families, it is a test of caring and patience. Our center is actively involved in both clinical and basic science research. Information about the available clinical trials and the latest developments in ALS research is continually updated on our website.

Learn more about ALS    
Our team of 21 professionals from 11 specialties uses a multidisciplinary approach to help patients with ALS to cope with their disease and applies the latest therapies and proactive symptom management in a positive and caring setting .

Patients can be either self-referred or physician-referred. Appointments to the center can be made only after one of our MDA/ALS team physicians has confirmed your diagnosis during a visit to Houston Methodist Hospital outpatient work-up unit, where you will be seen by all of the MDA/ALS "Team Hope" members. The cost of the diagnostic work-up will be the responsibility of the patient and/or the insurance carrier, but there is no direct cost to the patient for follow-up visits at the center. Visits to the center are covered by the patient's insurance and/or the Muscular Dystrophy Association.

Learn more about the MDA/ALS Center


Hear Karen's story about how she went from caregiver to ALS clinic coordinator


Hear Pastor Kevin Kinchen's inspiring story about his experience as our patient


Neuromuscular Clinical Trials
The MDA/ALS Center is involved with numerous neuromuscular drug trials; to be involved, you must first be evaluated and followed at the Methodist Neurological Institute Neuromuscular Clinical Center.
 
  • Oral Fingolimod in Patients with ALS (Amyotrophic Lateral Sclerosis)
  • A Trial of Pulse Steroid Therapy in ALS (Amyotrophic Lateral Sclerosis)
  • A Multicenter Study for the Validation of ALS Biomarkers
  • Pyrimethamine in Familial ALS (Amyotrophic Lateral Sclerosis)
  • CIDP PATH study of Subcutaneous IgPro20 (Phase III)
  • CD4+CD25+T Reg cells as Potential Biomarkers of Pathogenesis and Response to Therapy in CIDP Patients
  • Oral Fingolimod in CIDP

MDA Publications
Learn more about ALS and MDA in the following publications from the Muscular Dystrophy Association:

 

Our physicians specialize in managing amyotrophic lateral sclerosis (ALS), at the following convenient Houston Methodist locations


Houston Methodist Neurological Institute
MDA/ALS Center
6560 Fannin St.
Suite 802
Houston, TX 77030
713.441.3760